CDC

The U.S. Food and Drug Administration is expected to authorize Pfizer and Moderna’s COVID-19 vaccines for children as young as 6 months old. Read More

Vanderbilt research shows that two doses of an mRNA COVID-19 vaccine result in lower effectiveness for preventing hospitalization for the omicron variant than previous variants. However, importantly, a third (“booster”) vaccine dose significantly improves protection against omicron hospitalization up to 86%. Read More

Kelly Aldrich to lead year-long project modeling trends of hospital PPE. Read More

Hospital data from a CDC network that monitors influenza revealed that adults hospitalized for COVID-19 in the early months of the pandemic were 20x more likely to die compared to hospitalized influenza patients. Read More

The U.S. Centers for Disease Control and Prevention (CDC) has awarded Vanderbilt University Medical Center a two-year, $3.7-million contract to determine genetic and bacterial factors that may increase the risk for severe illness and death from COVID-19. Read More

Genomic sequences have revealed that Florida is a major source of a mosquito-borne virus that causes disease in horses and humans. Read More

Infectious Disease fellow Milner Staub, MD, is among the first awardees of the Leadership in Epidemiology, Antimicrobial Stewardship, and Public health (LEAP) Fellowship. Read More

The prevalence of U.S. children with autism spectrum disorder (ASD) is now 1 in 59, according to new estimates released Thursday by the Centers for Disease Control and Prevention (CDC), a significant increase from the 1 in 68 estimate in 2016. Read More

An influenza diagnosis for people 65 and older is serious. Up to 85 percent of influenza-related deaths occur in older adults, the Centers for Disease Control (CDC) and Prevention reports. Read More

Neighborhood determinants – represented by census tract data – contribute to the risk of influenza hospitalization and could be used to guide interventions such as vaccinations to high-risk areas. Read More

Vanderbilt University Medical Center (VUMC) Health and Wellness has received a Certificate of Full Recognition from the Centers for Disease Control and Prevention (CDC) for its diabetes prevention program for employees. Read More

Hepatitis C infections among pregnant women nearly doubled from 2009-2014, likely a consequence of the country’s increasing opioid epidemic that is disproportionately affecting rural areas of states including Tennessee and West Virginia. Read More

High dose flu vaccine boosts the immune response in older adults by increasing activation of certain immune cells. Read More

Summer is here, and the United States is bracing for the mosquito-transmitted Zika virus. A Vanderbilt researcher is working on one way to stop the spread of the disease – by revving up the mosquito’s taste buds. Read More

Dr. Annabelle de St. Maurice rapidly is ascending to the cutting edge of addressing the practical problems of world-impacting diseases. After earning her master’s degree in public health at Vanderbilt, in July 2015 she began work in Atlanta at the Centers for Disease Control and Prevention (CDC) as an Epidemic Intelligence Service (EIS) officer. Read More

In response to low national vaccination rates for the human papillomavirus (HPV), Vanderbilt-Ingram Cancer Center (VICC) has joined 68 of the nation’s other NCI-designated cancer centers in recommending increased HPV vaccination for the prevention of cancer. Read More

The Centers for Disease Control and Prevention (CDC) has issued a travel advisory for visitors to parts of South America, Central America, the Caribbean, Mexico, Samoa and Cape Verde where Zika virus transmission is ongoing. Read More

Viruses, not bacteria, are the most commonly detected respiratory pathogens in U.S. adults hospitalized with pneumonia, according to a New England Journal of Medicine study released today and conducted by researchers at Centers for Disease Control and Prevention (CDC) and hospitals in Chicago and Nashville, including Vanderbilt University Medical Center. Read More

Kathryn Edwards, M.D., director of the Vanderbilt Vaccine Research Program, has received a $307,000 grant from the Bill & Melinda Gates Foundation to study the immune responses of pregnant women who receive the Tdap (reduced-dose acellular pertussis vaccines combined with tetanus and diphtheria toxoids) vaccine. Read More

New Vanderbilt-led research shows hospitals are doing a better job of using antibiotics less commonly associated with antibiotic resistance to treat children hospitalized with community-acquired pneumonia (CAP). Read More